Page 14 - Read Online

Page 6 of 7 Thomas et al. Mini-invasive Surg 2018;2:17 I http://dx.doi.org/10.20517/2574-1225.2018.25

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Aitken RJ. Mesorectal excision for rectal cancer. Br J Surg 1996;83:214-6.
2. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am
Coll Surg 1995;181:335-46.
3. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ;
Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year
follow up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12:575-82.
4. Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, Martling A. Interim analysis of the Stockholm III trial of
preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010;97:580-7.
5. National Collaborating Centre for Cancer. Colorectal Cancer: The Diagnosis and management of Colorectal Cancer. Cardiff, United
Kingdom: National Collaborating Centre for Cancer; 2011.
6. Penninckx F, Kartheuser A, Van de Stadt J, Pattyn P, Mansvelt B, Bertrand C, Van Eycken E, Jegou D, Fieuws S; PROCARE. Outcome
following laparoscopic and open total mesorectal excision for rectal cancer. Br J Surg 2013;100:1368-75.
7. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ; COlorectal cancer Laparoscopic or Open Resection
II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised,
phase 3 trial. Lancet Oncol 2013;14:210-8.
8. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch
M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters
PW, Nelson H. Effect of laparoscopic assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the
ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
9. Hendren SK, O’Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, Macrae HM, Gryfe R, McLeod RS. Prevalence of male and female
sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212-23.
10. Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Hölzel D. Quality of life in rectal cancer patients: a four-year prospective study.
Ann Surg 2003;238:203-13.
11. Wilson TR, Alexander DJ. Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with
colorectal cancer. Br J Surg 2008;95:1408-15.
12. Wallner C, Lange MM, Bonsing BA, Maas CP, Wallace CN, Dabhoiwala NF, Rutten HJ, Lamers WH, Deruiter MC, van de Velde CJ;
Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Causes of fecal and urinary incontinence after total
mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch Total
Mesorectal Excision Trial. J Clin Oncol 2008;26:4466-72.
13. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin
M, Pucciarelli S, Small W Jr, Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL. Long-term outcome in patients with
a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol
2010;11:835-44.
14. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Geisler D, Dietz DW, Lavery IC, Fazio VW, Kalady MF. Pathologic complete
response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol
2011;18:1590-8.
15. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation
Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter,
nonrandomized phase ii prospective trial. Ann Surg 2011;254:97-102.
16. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD. assessing the predictive value of
clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002;194:131-5.
17. Chua YJ. Pathological complete response: still a relevant endpoint in rectal cancer? Lancet Oncol 2010;11:807-8.
18. Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation for distal rectal
cancer. Surg Oncol Clin N Am 2010;19:829-45.
19. Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, Mortensen NJ; Association of Coloproctology of Great Britain
and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration. Transanal endoscopic microsurgery (TEM) Collaboration. a
predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 2009;96:280-90.
20. Hallam S, Messenger D, Thomas M. A systematic review of local excision after neoadjuvant therapy for rectal cancer: are ypT0 tumors
the limit? Dis Colon Rectum 2016;59:984-97.
21. Norton SA, Thomas MG. Staging of rectosigmoid neoplasia with colonoscopic endoluminal ultrasonography. Br J Surgery 1999;86:942-
6.